- Report
- March 2021
Global
From €3145EUR$3,185USD£2,626GBP
€4493EUR$4,550USD£3,752GBP
- Report
- March 2021
Global
From €3145EUR$3,185USD£2,626GBP
€4493EUR$4,550USD£3,752GBP
- Report
- January 2021
Global
From €3145EUR$3,185USD£2,626GBP
€4493EUR$4,550USD£3,752GBP
- Report
- December 2020
- 142 Pages
Global
From €3145EUR$3,185USD£2,626GBP
€4493EUR$4,550USD£3,752GBP
- Report
- December 2020
- 86 Pages
Asia Pacific
From €2074EUR$2,100USD£1,732GBP
€2962EUR$3,000USD£2,474GBP
- Report
- August 2020
- 92 Pages
Asia Pacific
From €2074EUR$2,100USD£1,732GBP
€2962EUR$3,000USD£2,474GBP
- Report
- August 2020
- 126 Pages
North America
From €2074EUR$2,100USD£1,732GBP
€2962EUR$3,000USD£2,474GBP
- Report
- August 2020
- 86 Pages
Europe
From €2074EUR$2,100USD£1,732GBP
€2962EUR$3,000USD£2,474GBP
- Report
- October 2023
- 90 Pages
United Kingdom
From €3308EUR$3,350USD£2,762GBP
- Report
- May 2022
- 120 Pages
Global
From €4394EUR$4,450USD£3,669GBP
- Report
- December 2021
- 120 Pages
Global
From €4394EUR$4,450USD£3,669GBP
- Report
- October 2021
- 115 Pages
Global
From €4394EUR$4,450USD£3,669GBP
- Report
- July 2021
- 112 Pages
Global
From €4394EUR$4,450USD£3,669GBP
- Report
- April 2020
- 80 Pages
United States
From €2666EUR$2,700USD£2,226GBP
- Report
- November 2023
- 150 Pages
Global
From €4789EUR$4,850USD£3,999GBP
- Report
- October 2023
- 77 Pages
United States
From €3456EUR$3,500USD£2,886GBP
- Report
- November 2022
- 52 Pages
Global
From €4932EUR$4,995USD£4,119GBP
- Report
- August 2019
- 78 Pages
India
From €2728EUR$2,763USD£2,278GBP
€3209EUR$3,250USD£2,680GBP
- Report
- April 2023
- 119 Pages
Global
From €4443EUR$4,500USD£3,710GBP
- Report
- March 2023
- 116 Pages
Global
From €4443EUR$4,500USD£3,710GBP
The Biotechnology market has been affected by the pandemic in a variety of ways. Companies in the sector have had to adjust their operations to meet the demands of the new environment. Many have shifted their focus to developing treatments and vaccines for the virus, while others have had to pivot their operations to meet the needs of the changing market. Companies have also had to adjust their supply chains to ensure the safety of their products and services.
The pandemic has also had an impact on the financial performance of biotechnology companies. Many have seen their stock prices decline due to the uncertainty of the market. Additionally, the pandemic has caused a decrease in research and development spending, as well as a decrease in venture capital investments.
Notable companies in the biotechnology market include Gilead Sciences, Moderna, Regeneron Pharmaceuticals, and Novavax. These companies have all been involved in the development of treatments and vaccines for the virus. Additionally, they have all seen their stock prices increase due to the pandemic. Show Less Read more